NGS-Based RNA-Sequencing Market Driven by "Growth in Precision Medicine Market"


Posted April 20, 2020 by ddivya4086

NGS-based RNA-sequencing Market Report Provides Crucial Industry Insights That Will Help Your Business Grow. Know The Key Industry Trends.

 
According to the recent report “NGS-Based RNA-Sequencing Market by Product & Services (Sample Preparation, Platforms & Consumables, Services, Data Analysis), Technology (SBS, SMRT, Nanopore), Application (De Novo, Epigenetics, small RNA), End-User, Region - Global Forecast to 2024" The NGS-based RNA-sequencing market size is projected to reach USD 4.2 billion by 2024 from USD 1.7 billion in 2019, at a CAGR of 20.0% during the forecast period.

Browse in-depth TOC on “NGS-Based RNA-Sequencing Market”
87 – Tables
38 – Figures
156 – Pages

Market growth is driven mainly by the advantages of RNA-seq over conventional technologies; an increasing number of RNA-seq grants; rising number of research activities involving RNA-seq; and rapid growth in precision medicine market.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=102977816

The expression profiling analysis segment accounted for the largest share of the NGS-based RNA-sequencing market, by application, in 2018

Based on application, the NGS-based RNA sequencing market is segmented into expression profiling analysis, small RNA sequencing, De Novo transcriptome assembly, and variant calling & transcriptome epigenetics. In 2018, the expression profiling analysis segment accounted for the largest share of the NGS-based RNA sequencing market. The dominant market position of this segment is attributed mainly to the increasing prevalence of metabolic disorders, multiple sclerosis, and other diseases. These factors will continue to propel the demand for expression profiling analysis to provide specific treatment options in the market during the forecast period.

The nanopore segment is expected to register the highest growth in the NGS-based RNA-sequencing market, by type, during the forecast period

Based on technology, the NGS-based RNA-sequencing industry is segmented into sequencing by synthesis, ion semiconductor sequencing, single molecular real-time sequencing, and nanopore sequencing. Nanopore sequencing technology registers the highest growth rate in the market as it is the only sequencing technology with direct RNA-sequencing capabilities and facilitates sequencing of full-length RNA strands and modified RNA nucleotides using a simple library prep, without the need of conversion to double-stranded DNA.

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=102977816

North America dominated the NGS-based RNA-sequencing market

North America accounted for the largest share of the market in 2018. The large share of this region is the growing prevalence of target diseases, government support through funds for genomics research, advancements in RNA-Seq products, increasing research on cancer & inherited rare diseases, and the strong presence of key players such as Illumina (US), Thermo Fisher (US), and Agilent Technologies (US) in this region.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Healthcare News
Business Address United States
Country United States
Categories Biotech
Tags ngsbased rnasequencing , ngsbased rnasequencing market
Last Updated April 20, 2020